2. ANTIFUNGAL AGENTS
• common in Diabetes Mellitus, Cancer, AIDS,
Pregnancy and in patients on
immunosuppressive therapy such as
prolonged course of corticosteriods, broad
spectrum antibiotics, anticancer drugs, etc.
• Treatment of fungal infections is somewhat
difficult than bacterial infection because of
various factors.
3. Antifungal Drugs
• Fungal infectious occur due to :
• 1- Abuse of broad spectrum antibiotics
• 2- Decrease in the patient immunity
10. Classification According to Route of
Administration
• Systemic :
• Griseofulvin , Amphotericin- B , Ketoconazole , Fluconazole ,
Terbinafine.
• Topical
• In candidiasis :
• Imidazoles : Ketoconazole , Miconazole.
• Triazoles : Terconazole.
• Polyene macrolides : Nystatin , Amphotericin-B
• Gentian violet : Has antifungal & antibacterial.
11.
12. Amphotericin B
• Amphotericin A & B are antifungal antibiotics.
• Amphotericin A is not used clinically.
• It is a natural polyene macrolide
• (polyene = many double bonds )
• (macrolide = containing a large lactone ring )
13. Pharmacokinetics
• Poorly absorbed orally, is effective for fungal
infection of gastrointestinal tract.
• For systemic infections given as slow I.V.I.
• Highly bound to plasma protein .
• Poorly crossing BBB.
• Metabolized in liver
• Excreted slowly in urine over a period of several
days.
• Half-life 15 days.
14. Mechanism of action
• It is a selective fungicidal drug.
• Disrupt fungal cell membrane by binding to
ergosterol , so alters the permeability of the cell
membrane leading to leakage of intracellular ions &
macromolecules ( cell death ).
15.
16.
17.
18. Resistance to Amphotericin B
• If ergosterol binding is impaired either by :
• Decreasing the membrane concentration of
ergosterol.
• Or by modyfing the sterol target molecule.
19. Adverse Effects
• 1- Immediate reactions ( Infusion –related toxicity ).
• Fever, muscle spasm, vomiting ,headache, hypotension.
• Can be avoided by :
• A. Slowing the infusion
• B. Decreasing the daily dose
• C. Premedication with antipyretics, antihistamincs or
corticosteroids.
20. Slower toxicity
• Most serious is renal toxicity (nearly in all
patients ).
• Hypokalemia
• Hypomagnesaemia
• Impaired liver functions
• Thrombocytopenia
• Anemia
21. Clinical uses
• Has a broad spectrum of activity
• Fungicidal action.
• The drug of choice for life-threatening mycotic infections.
• For induction regimen for serious fungal infection.
• Also, for chronic therapy & preventive therapy of relapse.
• In cancer patients with neutropenia who remain febrile on
broad –spectrum antibiotics.
22. Routes of Administration
• 1- Slow I.V.I. For systemic fungal disease.
• 2- Intrathecal for fungal C.N.S. infections.
• Topical drops & direct subconjunctival injection for
Mycotic corneal ulcers & keratitis.
• 3- Local injection into the joint in fungal arthritis.
• 4- Bladder irrigation in Candiduria.
23. Liposomal preparations of
amphotericin B
• Amphotericin B is packaged in a lipid- associated
delivery system to reduce binding to human cell
membrane , so reducing :
• A. Nephrotoxicity
• B. Infusion toxicity
• Also, more effective
• More expensive
24. Azoles
• A group of synthetic fungistatic agents with a broad
spectrum of activity .
• They have
antibacterial
antiprotozoal
anthelminthic
antifungal activity .
25.
26. Mechanism of Action
• 1-Inhibit the fungal cytochrome P450 enzyme, (α-
demethylase) which is responsible for converting
lanosterol to ergosterol ( the main sterol in fungal
cell membrane ).
• 2- Inhibition of mitochondrial cytochrome oxidase
leading to accumulation of peroxides that cause
autodigestion of the fungus.
• 3- Imidazoles may alter RNA& DNA metabolism.
27. Azoles
• They are antibacterial , antiprotozoal, anthelminthic
& antifungal.
• They are fungistatic agents.
• They are classified into :
Imidazole group
Triazole group
28. Imidazoles
• Ketoconazole
• Miconazole
• Clotrimazole
• They lack selectivity ,they inhibit human gonadal
and steroid synthesis leading to decrease
testosterone & cortisol production.
• Also, inhibit human P-450 hepatic enzyme.
29. Ketoconazole
• Well absorbed orally .
• Bioavailability is decreased with antacids, H2
blockers , proton pump inhibitors & food .
• Cola drinks improve absorption in patients with
achlorhydria.
• Half-life increases with the dose , it is (7-8 hrs).
• Inactivated in liver & excreted in bile (feces ) &
urine.
• Does not cross BBB.
30. Clinical uses Adverse effects
• Used topically or
systematic (oral route
only ) to treat :
• 1- Oral & vaginal
candidiasis.
• 2- Dermatophytosis.
• 3- Systemic mycoses &
mucocutaneous
candidiasis.
• Nausea, vomiting
,anorexia
• Hepatotoxic
• Inhibits human P 450
enzymes
• Inhibits adrenal &
gonadal steroids leading
to :
• Menstrual irregularities
• Loss of libido
• Impotence
• Gynaecomastia in males
32. Fluconazole
• Water soluble, Completely absorbed from GIT
• Excellent bioavailability after oral administration
• Bioavailability is not affected by food or gastric PH
• Conc. in plasma is same by oral or IV route
• Penetrates well BBB so, it is the drug of choice of
cryptococcal meningitis
• Safely given in patients receiving bone marrow
transplants (reducing fungal infections)
• Excreted mainly through kidney
• Half-life 25-30 hours
• Resistance is not a problem
33. Clinical uses
• Candidiasis
• ( is effective in all forms
of mucocutaneous
candidiasis)
• Cryptococcus meningitis
• Histoplasmosis,
blastomycosis, , ring
worm.
• Not effective in
aspergillosis
Side effects
• Nausea, vomiting,
headache, skin rash ,
diarrhea, abdominal pain ,
reversible alopecia.
• Hepatic failure may lead to
death
• Highly teratogenic ( as
other azoles)
• Inhibit P450 cytochrome
• No endocrine side effects
34. Flucytosine (5-FC)
• Converted within the fungal cell to 5-
fluorouracil( Not in human cell ), that inhibits
thymidylate synthetase enzyme that inhibits DNA
synthesis.
• ( Amphotericin B increases cell permeability ,
allowing more 5-FC to penetrate the cell, they are
synergistic).
35. Griseofulvin
• Fungistatic, has a narrow spectrum
• Given orally (Absorption increases with fatty meal )
• Half-life 24 hours
• Taken selectively by newly formed skin &
concentrated in the keratin.
• Induces cytochrome P450 enzymes
• Should be given for 2-6weeks for skin & hair
infections to allow replacement of infected keratin
by the resistant structure
36. Griseofulvin(cont.)
• Inhibits fungal mitosis by interfering with microtubule
function
• Used to treat dermatophyte infections ( ring worm of skin,
hair, nails ).
• Highly effective in athlete,
s foot.
• Ineffective topically.
• Not effective in subcutaneous or deep mycosis.
• Adverse effects ;
• Peripheral neuritis, mental confusion, fatigue, vertigo,GIT
upset,enzyme inducer, blurred vision.
• Increases alcohol intoxication.